Gladstone Institutional Advisory’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$104K Hold
2025
Q2
$52K Hold
2025
Q1
$30.1K Hold
2024
Q4
$31.8K Buy
2024
Q3
$59.8K Buy